Preview: 

_______________________________________________________________________________________________

July 14th, 2020

  by Dr. Elizabeth Lee Vliet

Stunning positive news on hydroxychloroquine (HCQ) was released in early July, potentially opening up medical freedom at the time of America’s celebration of our Declaration of Independence from British tyranny 244 years ago.

During the first six days of July, SIX positive clinical studies of HCQ were released:

  •  three from the United States (one from Michigan at Henry Ford Health System, and two from New York state, including one primary care outpatient study by Dr. Vladimir Zelenko
  • three from other countries (Portugal, India, and Brazil).

All six studies showed that HCQ given early in COVID-19, alone or with zinc and azithromycin, reduces hospitalizations and deaths, with no serious heart or other adverse events.

Most media ignored these six positive studies, continuing to focus on fearmongering about HCQ “dangers” from now discredited, poorly designed and seriously flawed reports on use in critically ill hospitalized patients.

The Henry Ford study showed a 50 percent reduction in the death rate when HCQ was used early in hospitalized COVID patients. Dr. Zelenko’s even earlier outpatient intervention with HCQ, azithromycin and zinc showed approximately 80% decrease in deaths. These extraordinary results show how many lives can be saved with early HCQ treatment.

Henry Ford physicians, researchers, and ethicists have filed an urgent application with FDA Commissioner Dr. Hahn for a new Emergency Use Authorization (EUA) for early, out-patient HCQ use in COVID-19.

Baylor Scott & White Heart and Vascular Institute in Dallas issued an urgent letter in support of the Henry Ford new outpatient EUA application, based on the remarkably positive outcomes in their own clinical study of prophylactic use of HCQ in their own medical workers. More